致死性肺发育障碍的临床、组织病理与分子诊断
致死性肺发育障碍是表现为新生儿呼吸衰竭的罕见儿童弥漫性肺疾病,组织病理包括肺泡毛细血管发育不良伴肺静脉错位、腺泡发育不良、先天性肺泡发育不良等。近十年发现FOXF1基因及16q24.1非编码调控变异、TBX4-FGF10-FGFR2信号通路破坏参与发病,建议采用全基因组测序的诊断路径。
要点
- 致死性肺发育障碍包括ACDMPV、腺泡发育不良、先天性肺泡发育不良等,组织病理呈连续谱。
- FOXF1剂量敏感基因及16q24.1非编码调控变异是ACDMPV的致病原因。
- TBX4-FGF10-FGFR2信号通路破坏见于致死性肺发育不良,建议全基因组测序辅助诊断。
核心结论
- 非编码调控元件在人类肺发育中起关键作用,致死性肺发育障碍的诊断应纳入全基因组测序。
研究设计与样本
- 综述性文章,总结致死性肺发育障碍的临床、组织病理和分子诊断进展,未报告具体样本量。
主要发现
- 肺泡毛细血管发育不良伴肺静脉错位由FOXF1基因及16q24.1非编码调控变异导致。
- 腺泡发育不良和先天性肺泡发育不良的分子基础长期不清,近期发现TBX4-FGF10-FGFR2信号通路破坏。
- 外显子组和全基因组测序揭示这些疾病的复杂复合遗传模式。
临床怎么用
- 对新生儿呼吸衰竭且疑诊致死性肺发育障碍的患儿,应考虑包含全基因组测序的诊断路径以提高诊断准确性。
局限性
- 腺泡发育不良和先天性肺泡发育不良的分子基础仍知之甚少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lethal lung developmental disorders are a rare but important group of pediatric diffuse lung diseases presenting with neonatal respiratory failure. On the basis of histopathological appearance at lung biopsy or autopsy, they have been termed: alveolar capillary dysplasia with misalignment of the pulmonary veins, acinar dysplasia, congenital alveolar dysplasia, and other unspecified primary pulmonary hypoplasias. However, the histopathological continuum in these lethal developmental disorders has made accurate diagnosis challenging, which has implications for recurrence risk. Over the past decade, genetic studies in infants with alveolar capillary dysplasia with misalignment of the pulmonary veins have revealed the causative role of the dosage-sensitive FOXF1 gene and its noncoding regulatory variants in the distant lung-specific enhancer at chromosome 16q24.1. In contrast, the molecular bases of acinar dysplasia and congenital alveolar dysplasia have remained poorly understood. Most recently, disruption of the TBX4-FGF10-FGFR2 epithelial-mesenchymal signaling pathway has been reported in patients with these lethal pulmonary dysplasias. Application of next-generation sequencing techniques, including exome sequencing and whole-genome sequencing, has demonstrated their complex compound inheritance. These data indicate that noncoding regulatory elements play a critical role in lung development in humans. We propose that for more precise lethal lung developmental disorder diagnosis, a diagnostic pathway including whole-genome sequencing should be implemented.
引用
- Vincent M, Karolak JA, Deutsch G, et al. Clinical, Histopathological, and Molecular Diagnostics in Lethal Lung Developmental Disorders. Am J Respir Crit Care Med. 2019. PMID: 31189067. doi:10.1164/rccm.201903-0495TR
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。